- Home
- FENG vs CRIS Comparison
FENG vs CRIS Comparison
Compare FENG & CRIS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FENG
- CRIS
- Stock Information
- Founded
- FENG 1998
- CRIS 2000
- Country
- FENG China
- CRIS United States
- Employees
- FENG N/A
- CRIS N/A
- Industry
- FENG Broadcasting
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- FENG Industrials
- CRIS Health Care
- Exchange
- FENG Nasdaq
- CRIS Nasdaq
- Market Cap
- FENG 29.7M
- CRIS 32.8M
- IPO Year
- FENG 2011
- CRIS 2000
- Fundamental
- Price
- FENG $2.49
- CRIS $3.29
- Analyst Decision
- FENG
- CRIS Strong Buy
- Analyst Count
- FENG 0
- CRIS 3
- Target Price
- FENG N/A
- CRIS $23.00
- AVG Volume (30 Days)
- FENG 3.6K
- CRIS 243.3K
- Earning Date
- FENG 03-11-2025
- CRIS 02-06-2025
- Dividend Yield
- FENG N/A
- CRIS N/A
- EPS Growth
- FENG N/A
- CRIS N/A
- EPS
- FENG N/A
- CRIS N/A
- Revenue
- FENG $99,426,474.00
- CRIS $10,259,000.00
- Revenue This Year
- FENG N/A
- CRIS N/A
- Revenue Next Year
- FENG N/A
- CRIS N/A
- P/E Ratio
- FENG N/A
- CRIS N/A
- Revenue Growth
- FENG N/A
- CRIS 0.44
- 52 Week Low
- FENG $1.20
- CRIS $2.86
- 52 Week High
- FENG $4.15
- CRIS $17.49
- Technical
- Relative Strength Index (RSI)
- FENG 51.73
- CRIS 44.97
- Support Level
- FENG $2.31
- CRIS $3.10
- Resistance Level
- FENG $2.65
- CRIS $3.60
- Average True Range (ATR)
- FENG 0.11
- CRIS 0.37
- MACD
- FENG 0.01
- CRIS 0.00
- Stochastic Oscillator
- FENG 54.29
- CRIS 26.22
About FENG Phoenix New Media Limited
Phoenix New Media Ltd is a media company providing premium content on an integrated platform across the internet, mobile and TV channels in China. The company organizes its operations into two main segments: Net advertising services and Paid services. It provides its content and services through three channels: ifeng.com channel, video channel, and mobile channel. The company also offers a wide range of paid services including mobile value-added services, games, and content sales. It generates the majority of its revenue from Net advertising services. Geographically, it derives revenue from China.
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes innovative drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, advanced solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.